FULL FACTORIAL DESIGN IN FORMULATION OF LAMOTRIGINE SUSPENSION USING LOCUST BEAN GUM

Similar documents
STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Optimization of valsartan tablet formulation by 2 3 factorial design

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

DEVELOPMENT AND EVALUATION OF ORAL RECONSTITUTABLE SYSTEMS OF CEPHALEXIN

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS AND SOLUTOL HS15 - A FACTORIAL STUDY

Asian Journal of Pharmacy and Life Science ISSN Vol.3 (2), April-June, 2013

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

Design and Optimization of Rivaroxaban Lipid Solid Dispersion for Dissolution Enhancement using Statistical Experimental Design. ), and Labrasol (X 3

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL

LABORATORY MANUAL PHM 2143 PHYSICAL PHARMACY II

Formulation and evaluation of immediate release salbutamol sulphate

Optimisation of Orodispersible Tablet of Amlodepine, Ramipril in Fixed Dose Combination by Using Quality by Design (QbD) Approach

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

Available online Research Article

International Journal of Medicine and Pharmaceutical Research

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

OBJECTIVES INTRODUCTION

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

Shweta Vashist. et al. / International Journal of Biopharmaceutics. 2015; 6(1): International Journal of Biopharmaceutics

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Behaviors of Polysaccharide Solution, Dispersions and Gels

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

Gums--Food functions. Gums--General functions. Behaviors of Polysaccharide Solution, Dispersions and Gels

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Texturizing Solutions: Serving customers across categories

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-1, 2017, 1-7 Research Article Open Access.

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF ACECLOFENAC BY SOLID DISPERSION IN STARCH PHOSPHATE AND GELUCIRE

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

Development and Validation of a New Uv Method for the Analysis of Rebamipide

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India

Folic Acid in Human Nutrition

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

Received on: Accepted on:

Studies on Curcuma angustifolia Starch as a Pharmaceutical Excipient

Formulation and evaluation of fast dissolving tablet of aceclofenac

Formulation and evaluation of sustained release atenolol

Formulation and Evaluation

OPTIMIZATION OF RICE BRAN HYDROLYSIS AND KINETIC MODELLING OF XANTHAN GUM PRODUCTION USING AN ISOLATED STRAIN

ISSN: X CODEN: IJPTFI Available Online through Research Article

skim milk as carrier by kneading method. They were evaluated for percentage yield, drug content, FT-IR

International Journal of Pharmacy

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

EFFECT OF PVP ON CYCLODEXTRIN COMPLEXATION OF EFAVIRENZ FOR ENHANCING ITS SOLUBILITY AND DISSOLUTION RATE

EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Optimizing Surfactant Systems Thickened with Carbopol * ETD 2020 Polymer Using a Statistical Design

Biowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman

International Journal of Innovative Pharmaceutical Sciences and Research

Journal of Chemical and Pharmaceutical Research

Formulation and evaluation of oral dispersible tablets of aripiprazole

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LIQUID PREPARATIONS FOR ORAL USE

International Journal on Future Revolution in Computer Science & Communication Engineering ISSN: Volume: 4 Issue:

Available online at

Journal of Chemical and Pharmaceutical Research, 2018, 10(2): Research Article

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Emulsions. Purpose of emulsions and of emulsification:

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Functional Properties of Foods. Database and Model Prediction

Available Online through Research Article

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

K. Ravi Shankar et al. /BioMedRx 2013,1(3), Available online through

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Preparation and Evaluation of Ethyl Cellulose Coated Microcapsules of Carbamazepine for Controlled Release

Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System

Stability Of Extemporaneously Prepared Oral Liquid Formulations Part XI

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS

Establishment of blending control for Hand operated Double Cone Blender

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

5 Optimisation of Process Parameters of L- asparaginase production by isolate SI091

pharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the

Xanthan Gum. Regulatory Status

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

Fabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based sustained release matrix tablets

Transcription:

Int. J. Chem. Sci.: 11(2), 2013, 751-760 ISSN 0972-768X www.sadgurupublications.com FULL FACTORIAL DESIGN IN FORMULATION OF LAMOTRIGINE SUSPENSION USING LOCUST BEAN GUM A. PRAMEELA RANI a and HEMA VEESAM * KVSR Siddhartha College of Pharmaceutical Sciences, VIJAYAWADA 520010 (A.P.) INDIA a University College of Pharmaceutical Sciences, Acharya Nagarjuna University, GUNTUR 522510 (A.P.) INDIA ABSTRACT Lamotrigine, a weakly basic, anticonvulsant drug have high permeability but poor solubility belonging to BCS Class II. The aim of this work was to formulate suspension in order to improve the bioavailability and patient compliance. In the present investigation, a perfect suspension was made using Locust bean gum, sodium alginate as viscosity enhancers and sodium citrate as anti-flocculant. Using 2 level 3 factor full factorial design, amount of ingredients were selected as independent variables while viscosity and sedimentation volume as response or dependent variables. The responses of data were recorded and analyzed for ANOVA, the individual parameters were evaluated by polynomial equation for each response generated using multiple linear regression analysis. The relationship between dependent and independent variables was further elucidated using contour plots finally optimized for desired response. From the results the eight formulations were made by factorial design, later optimized batch was prepared after desirability analysis and validated the obtained value with predicted showing good reliability of the design, highest r 2 and lowest sum of squares of residual was observed for the responses. Thus the prepared suspension showed high sedimentation volume, high redispersibility and optimum viscosity following non-newtonian type behavior. Key words: Lamotrigine, Full factorial design, Locust bean gum, Suspension. INTRODUCTION Lamotrigine (LMT) is a novel antiepileptic agent belonging to Biopharmaceutical Classification System II with oral bioavailability of about 98% 1. It is available as tablet with various strengths such as 25 mg, 50 mg and 100 mg. In the present work, LMT was designed with a view to enhance patient compliance and thus formulated into suspension. The oral route of drug administration is the most important method of administering drugs for systemic effect. Among all the forms liquid form is preferred class of dosage forms for the * Author for correspondence; E-mail: hemavpharma@gmail.com; Ph.: 9440014336

752 A. P. Rani and H. Veesam: Full Factorial Design in. reasons that high rate of bioavailability, better organoleptic properties and ease of administration 2. Based on electrokinetic properties, suspensions are of flocculated and deflocculated type 3. In this study, carob gum was used as viscosity enhancer which can also act as stabilizing agent and suspending agent. It is a yellowish-green, odorless powder and was 5 times effective than starch where there was no ADI as per WHO 4. Much of the work was focused on controlled release liquid formuation 5, nanosuspension 6. From different optimization methodologies such as simultaneous where experimentation is completed before optimization was important like factorial design where target value of objective can be measured by optimization 7. Factorial design was a first degree model because they have maximum efficiency in estimating main effects. The obtained mathematical model from these designs describe factor-response relationship as quadratic equation regardless the results were validated by contour plots and further the results are typically interpreted from ANOVA 8. The main purpose of this work was only to improve patient compliance without compromising the therapeutic efficacy. The objective of this study was also to investigate the combined effect of viscosity enhancers and anti-flocculant using full factorial design. Materials and methods EXPERIMENTAL Lamotrigine was obtained as gift sample from Dr Reddy s Labs, Hyderabad, India. Locust bean gum (LBG) was gifted from Rhodia organic fine Ltd, UK. Sodium alginate (SA), Sodim Citrate (SC) was obtained as gift sample from FMC biopolymer, USA and Fischer Scientific, UK. Remaining all other excepients and chemicals were obtained from local suppliers. Experimental design A selected two level, three factor experimental design describe the proportion in which the independent variables LBG, SA and SC were used in formulation of LMT suspension. The viscosity and sedimentation volume were selected as dependent variables. All eight formulations were prepared in three sets and analyzed individually for viscosity and sedimentation volume in triplicate. The linear regression model was derived from systat version 10, statistical software. Significance terms were chosen at 95% confidence interval (p < 0.05) for final equations. In addition, contour plots were obtained to represent the effect of the independent variables graphically.

Int. J. Chem. Sci.: 11(2), 2013 753 Formulation of LMT suspension LMT was formulated into suspension with various inactive ingredients such as LBG, SA as viscosity enhancers, SC as anti-flocculant, sodium benzoate as preservative and sodium saccharin as sweetener. All ingredients were weighed and passed through 40 #, firstly LBG, SA were dissolved in water before 24 h. Later SC, sodium benzoate was added and dissolved. Then drug was added to the solution and dispersed, finally sodium saccharin and flavorant were added. Formulation optimization From the computation for optimized formulation, the response variables considered for optimization were sedimentation volume and viscosity. The optimized formulation was obtained by applying constraints (goals) on dependent (response) and independent variables (factors). Determination of viscosity Brookfield viscometer (Spindle LV model) was used to measure viscosity. 1 ml of fluid was taken in cup and bob was allowed to completely immerse in the cup. Viscometer was switch on, run it till indicator shifted from red zone to green zone. Viscometer was allowed to run in both ascending and descending mode (10-100 rpm) at 5 min. interval and 1 min. data collection interval time. Determination of sedimentation volume 20 ml of solution was taken in 50 ml glass measuring cylinder. The suspension was dispersed thoroughly by moving upside down for three times and volume of sedimentation was noted (V 0 ). Later suspension was allowed to settle for 24 h and volume was read (V u ). Assessment of re-dispersibility F = Suspension was allowed to settle in measuring cylinder. Mouth of cylinder was closed and was inverted through 180 and number of inversions required for restoration was noted. If uniformity attained in one inversion, then it has 100% redispersibility. Every additional inversion decreases the percentage of ease of redispersibility by 5%. V 0 V u

754 A. P. Rani and H. Veesam: Full Factorial Design in. RESULTS AND DISCUSSION Preparation and characterization of suspension The different suspension formulations were prepared at various coded values for locust bean gum, sodium alginate and sodium citrate (Table 1 and 2). Table 1: 2 3 full factorial design for suspension formulation Formulation Locust bean gum Sodium alginate Sodium citrate Percentage Actual amount Percentage Actual amount Percentage Actual amount F1 1 1.5 2 3 2 3 F2 1 1.5 2 3 4 6 F3 1 1.5 4 6 2 3 F4 1 1.5 4 6 4 6 F5 4 6 2 3 2 3 F6 4 6 2 3 4 6 F7 4 6 4 6 2 3 F8 4 6 4 6 4 6 Table 2: Formulation table of lamotrigine suspension Formulation code Drug Locust bean gum Sodium alginate Sodium citrate Sodium benzoate Sodium saccharin Flavor Distilled water (ml) A1 250 7.5 15 15 3.75 458.75 qs 20 A2 250 7.5 15 30 3.75 443.75 qs 20 A3 250 7.5 30 15 3.75 443.75 qs 20 A4 250 7.5 30 30 3.75 428.75 qs 20 A5 250 30 15 15 3.75 436.25 qs 20 A6 250 30 15 30 3.75 421.25 qs 20 A7 250 30 30 15 3.75 421.25 qs 20 A8 250 30 30 30 3.75 406.25 qs 20 20 ml of suspension was prepared containing 50 mg of drug in 4 ml of suspension

Int. J. Chem. Sci.: 11(2), 2013 755 Assessment of viscosity and sedimentation volume As per the prescribed specifications, the concentrations were selected for LBG, SA and SC. The obtained results for viscosity and sedimentation volume (Table 3) explains that with high ratios of locust bean gum and sodium alginate, the viscosity increases drastically and with increase in sodium citrate, the sedimentation volume in increases and in order to obtain the desired value, experimental design was used. Table 3: Suspension evaluation responses (mean ± standard deviation) Formulation A1 A2 A3 A4 A5 A6 A7 A8 Appearance Vis. (cp) 60 82 121 103 172 180 210 181 SV (24 h) 0.23 0.74 0.76 0.95 0.44 0.79 0.90 0.95 Redispersibility (%) 90 95 90 90 90 95 95 90 Experimental designing and analysis of variance Full factorial design was used to investigate the effect of 3 factors; the effects of independent variables upon responses were modeled from polynomial equation for viscosity and sedimentation volume as represented in Table 4. Table 4: Regression equations for the responses YSV = -1.246C + 0.138LBG + 0.433SA + 0.428SC 0.025LBG*SA 0.078SA*SC- 0.010LBG*SC YVisc = -108.04C + 48.417LBG + 31.958SA + 52.958SC 83LBG*SA 9.625SA*SC- 83LBG*SC SV-Sedimentation volume; Visc-Viscosity; LBG-Locust bean gum; SA-Sodium alginate; SC-Sodium citrate These fitted equations relate the responses, showed good correlation coefficient of 0.999. The results reveal the good reproducibility of the system. The regression equations draw conclusions after considering the magnitude of the coefficient and the mathematical equation carries positive sign in the polynomial equation indicating that the response increases with increase in the value and negative sign represents the decrease in response with increase in the value. The interaction terms showed how the response changes when two factors were simultaneously changed. From contour plots only, the formulation

756 A. P. Rani and H. Veesam: Full Factorial Design in. optimization for required response was predicted graphically. The criteria for selecting the most appropriate model are lowest sum of square of residuals (SSR) and highest r 2 value indicates linearity of data (Table 5). Residual values of predicted and observed data were used to calculate sum of squares of residuals in ANOVA. Table 5: Analysis of Variance (ANOVA) of dependent variables Dependent variables Source of variation Degree of freedom Sum of squares Mean square F-ratio calculated (tabular) P- value Sedimentation volume (Y SV ) Regression residuals total R 2 6 1 7 1.000 0.464 0.0 0.464 0.077 0.0 1545.2 (234) 0.019 Viscosity (Y VISC ) Regression residuals total R 2 6 1 7 0.999 20682.7 1.125 20683.9 3447.12 1.125 3064.1 (234) 0.014 Constraints for optimization as desirability analysis (Table 6) were used and exact amount of LBG, SA and SC for achieving desired response was found out from optimization; desirability 1.0 indicated optimum formulation was achieved at 29 mg of LBG, 17 mg of SA and 29 mg of SC (Table 7). Validation of optimization technique done by preparing optimized batch, response was evaluated and compared to predicted response. Table 6: Constraints for optimization Response Lower value Target Upper value Sedimentation volume 0.23 0.94 0.95 Viscosity 60 200 210 Table 7: Optimization through desirability approach Factor Stationary point Coded Uncoded (%) Amount Taragum 0.919 3.878 29.085 Sodium alginate -0.667 2.333 17.497 Sodium citrate 0.889 3.889 29.167

Int. J. Chem. Sci.: 11(2), 2013 757 (a) 4.5 (b) Sodalginate Sodcitrate 4.0 1.5 0 1 2 3 4 5 LBG 4.5 (c) 4.0 1.5 0 1 2 3 4 5 LBG 4.5 4.0 (d) Sodcitrate Sodalginate Sodcitrate 1.5 1.5 4.0 4.5 Sodalginate (e) 4.5 4.0 Sodcitrate 1.5 0 1 2 3 4 5 LBG 4.5 (f) 4.0 1.5 0 1 2 3 4 5 LBG 1.5 1.5 4.0 4.5 Sodalginate Fig. 1: Contour plots by the effect of LBG, SA and SC on (a), (b), (c) sedimentation volume and (d), (e), (f) viscosity

758 A. P. Rani and H. Veesam: Full Factorial Design in. Thus finally the prepared formulation was observed its viscosity in order to state the type of flow behavior. From the Fig. 2, at different rates of speed, viscosity decreases with rate of shear (Table 8) indicating the pseudo-plastic flow behavior of the fluid 9. In non- Newtonian systems, one point determination is virtually useless in characterizing the flow properties of the system. Thus multipoint instrument that operates at a variety of rates of shear was opted where tackiness, slip and spreadability are easy to measure. The Fig. 3 clearly represents that it follows non-newtonian pseudo-plastic flow behavior. Under several types of behavior observed when the rate of shear progressively increased and plotted against the resultant shear stress. Visocosity (cp) 300 250 200 Shear stress (dy/cm 2 ) 20 40 60 80 100 120 0 20 40 60-1 Rate of shear (sec. ) 150 80 0 50 100 150 Speed (rpm) Fig. 2: Influence of rotational speed, shear stress and rate of shear on viscosity of optimized formulation 70-1 Rate of shear (sec. ) 60 50 40 30 20 10 0 0 15 30 45 60 75 90 105 Shearing stress (dy/cm 2 ) Fig. 3: Relationship between shearing stress vs rate of shear

Int. J. Chem. Sci.: 11(2), 2013 759 Table 8: Viscosity parameters of optimized formulation Rotational speed (rpm) Viscosity (cp) Shearing stress (dy/cm 2 ) Rate of shear (sec -1 ) Torque (%) 10 242 22 9.09 11.83 25 226 43 19.03 23.12 50 204 61 29.90 32.79 75 187 84 44.92 45.16 100 171 103 60.23 55.38 100 168 102 60.71 54.84 75 186 81 45 45 50 202 58 28.71 31.18 25 223 41 18.38 22.10 10 241 17 7.05 9.14 In the non-newtonian system with shear-thinning systems, the down-curve is frequently displaced to the left of the up-curve showing that the material has a lower consistency at any one rate of shear on the down-curve than it had on the up-curve. This indicates a break down of the structure that does-not reform immediately when the stress is removed or reduced which is known as thixotropy that is most commonly exhibited by shear-thinning systems. CONCLUSION From above work, LMT suspension formulation was made using locust bean gum and other ingredients in order to enhance the patient compliance and this method may minimize the number of trials in final optimization there by improving formulation development process. ACKNOWLEDGMENT The authors are thankful to the Principal Dr. G Devala Rao, PG Director Dr. Buchi Nalluri, Mr. Digpathi Roy and the Management of KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada for providing necessary facilities and constant support all through the work. Bhadrayya K, Director, Swaroop Tech Consultancy for his support over optimization techniques.

760 A. P. Rani and H. Veesam: Full Factorial Design in. REFERENCES 1. L. Mladena, P. Ana, G. K. Svetlene and G. B. Ksenija, Comparison of Dissolution Profiles and Serum Concentrations of Two Lamotrigine Tablet Formulations; Drugs in R & D, 11(1), 53-60 (2011). 2. E. J. Kennedy, Suspensions, Pharmaceutical Practice, 3 Ed., Churchill Livingstone, Ch. 18 (2004) p. 191-196 3. A. T. Florence and D. Attwood, Emulsions, Suspensions and Other Dispersions; Physicochemical Principles of Pharmacy, 3 Ed., Macmillan Press, Hampshire (1998) pp. 252-307. 4. European Parliament and Council Directive 95/2/EC on Food Additives Other Than Colors and Sweeteners, Official J. European Comm.. No L61/1-40, 18.3.95. E410. 5. B. Mishra, B. L. Sahoo, M. Mishra, D. Shukla and V. Kumar, Design of a Controlled Release Liquid Formulation of Lamotrigine, DARU J. Pharm. Sci., 19(2), 126-137 (2011). 6. B. Mishra, N. Arya and S. Tiwari, Investigation of Formulation Variables Affecting the Properties of Lamotrigine Nanosuspension using Fractional Factorial Design; DARU J. Pharm. Sci., 18(1), 1-8 (2010). 7. Sanford Bolton, Factorial Designs, Pharmaceutical Statistics: Practical and Clinical Applications; Ed.3, Marcel Dekker, Inc. NY, Ch. 9 (1990) p. 308-336. 8. J. Shridhar, Statistical Optimization of Drug Formulation using Factorial Design; Pharmainfo.net (2008). 9. M. L. Medvidova and A. Zauskova, Numerical Modeling of Shear-Thinning Non- Newtonian Flows in Compliant Vessels, Int. J. Numer. Meth. Fluids, 1, 1-6 (2007). Revised : 22.2013 Accepted : 24.02.2013